Cargando…
Response measures influence comparative effectiveness of biological drugs in rheumatoid arthritis
Autores principales: | Canhao, Helena, Romao, Vasco, Martins, Fernando, Fonseca, Joao Eurico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509023/ http://dx.doi.org/10.1186/1479-5876-10-S3-P52 |
Ejemplares similares
-
Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?
por: Romão, Vasco Crispim, et al.
Publicado: (2013) -
Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?
por: Romão, Vasco C., et al.
Publicado: (2017) -
Disease mechanisms in preclinical rheumatoid arthritis: A narrative review
por: Romão, Vasco C., et al.
Publicado: (2022) -
TRAF1/C5 locus is associated with response to anti-TNF in rheumatoid arthritis
por: Canhão, Helena, et al.
Publicado: (2012) -
Etiology and Risk Factors for Rheumatoid Arthritis: A State-of-the-Art Review
por: Romão, Vasco C., et al.
Publicado: (2021)